ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

NCI To Sponsor Its Own Predoctoral Training At Some Institutions With Postdoctoral Awards

January 31, 1975